Nelson Vergel
Founder, ExcelMale.com
Xyosted Prefilled Autoinjector for Subcutaneous Testosterone Administration
Conclusion Authentic needle and drug-containing devices were used in order to provide a realistic assessment of the potential for limitations of usability with the SCTE-AI device. Results of this usability validation study indicate the low potential for physical harm associated with use of the...
www.excelmale.com
Xyosted : QuickShot testosterone auto injector by Antares Pharma
This autoinjector will be approved by the end of 2017 in the U.S. The double-blind, multicenter Subcutaneous Testosterone Efficacy and Safety in Adult Men Diagnosed with Hypogonadism (STEADY) trial of a novel, pre-filled auto injector enrolled 150 hypogonadal adult men with two baseline...
www.excelmale.com
Post-market single center experience with a subcutaneous auto-injector of testosterone enanthate (Xyosted)
Introduction & Objectives: Xyosted is the first Food and Drug Administration (FDA)-approved testosterone enanthate product aimed to provide a weekly, self-administered injector for subcutaneous delivery of testosterone. This is the first non-industry sponsored post-market study to evaluate the...
www.excelmale.com
